Ebit تغيير تاريخ
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Daiichi Sankyo JPY 27.08B 72.41B 2024-03
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
Incyte USD 376.26M 121.03M 2024-12
Insmed USD -245214000 31.78M 2024-12
Ionis Pharmaceuticals USD -110000000 38M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
PTC Therapeutics USD -162389000 107.88M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Tectonic Therapeutic USD -19637000 8.22M 2024-09
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Sarepta Therapeutics - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.